"Current extramural fetal tissue research funded by NIH grants - that is, conducted at universities and other centers outside the NIH - won't be affected by the new policy, but "[for] new extramural research grant applications or current research projects in the competitive renewal process (generally every 5 years) that propose to use fetal tissue from elective abortions and that are recommended for potential funding.an ethics advisory board will be convened to review the research proposal and recommend whether, in light of the ethical considerations, NIH should fund the research project - pursuant to a law passed by Congress", the statement said.
Officials said Wednesday that government-funded research by universities would be allowed to continue, subject to additional scrutiny.
In 2018, the Department of Health and Human Services (HHS) began reviewing all federal research involving human foetal tissue and halted any new acquisition of tissue.
"That really requires more research and requires tissues such as this to do that research", said Schekman, "There are many elected abortions that are still legal in this country and that tissue would otherwise be discarded".
This will not now impact government-funded research by universities.
Administration officials said the federal policy changes will not affect privately funded research.
"The protection and care of human life by physicians and researchers must exist at all stages of life from conception to natural death", she said in a statement.
Fetal tissue has been used for a wide variety of research in the US dating back to the 1930s, including the development of several vaccines and studies of genetic diseases.
That same month, the UCSF the lab that its contract for HIV research involving fetal tissue would be extended another three months while the HHS performed an audit of the lab's practices.
The University of California, San Francisco, the one losing its contract, said in response that the Trump administration's decision was politically motivated. Scientists around the country denounced the decision, saying that fetal tissue was critically needed for research on HIV vaccines, treatments that harness the body's immune system to battle cancer, and other health threats, including some to fetuses themselves.
This move follows a review conducted by the Department of Health and Human Services which looked at "all HHS research involving human fetal tissue from elective abortions", according to the announcement. "It is outrageous and disgusting that we have been complicit, through our taxpayer dollars, in the experimentation using baby body parts".
Per the Associated Press, a senior first price talked about the policy transfer came from President Donald Trump, no longer the NIH Director, Francis Collins. "It blocks important future research vital to the development of new therapies." says Dr. Lawrence Goldstein, regenerative medicine specialist.
Kristan Hawkins, president of Students for Life of America, said in a statement that the administration has "once again done the right thing in restoring a culture of life to our government".
Pro-life groups have argued that experiments can be can used with ethical alternatives, such as adult stem cells, while some top scientific organizations have argued that the tissue is necessary for certain types of research, leading to the development of HIV drugs and rabies and rubella vaccines.
The scientific community has been adamant that no alternatives to human fetal tissue have proven equally effective.
Testifying on behalf of the Charlotte Lozier Institute, which opposes abortion, biochemist Tara Sander Lee said tissues from infants who have to have heart surgery are among the alternatives.
Research involving fetal tissue accounted for $98 million in NIH grants and projects during the 2017 budget year, a small fraction of the agency's overall research budget.